{
    "2021-05-07": [
        [
            {
                "time": "",
                "original_text": "益方生物IPO尚无药品上市销售，管理层分摊巨额股份支付费至亏损突增？ 亏损",
                "features": {
                    "keywords": [
                        "益方生物",
                        "IPO",
                        "药品",
                        "股份支付费",
                        "亏损"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "机会来了！这些公司有望调入沪深300、上证50指数",
                "features": {
                    "keywords": [
                        "机会",
                        "公司",
                        "沪深300",
                        "上证50"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中金：医药、新能源多只股票或将纳入沪深300指数",
                "features": {
                    "keywords": [
                        "中金",
                        "医药",
                        "新能源",
                        "沪深300"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中金公司：医药、新能源行业多只股票或将纳入沪深300指数",
                "features": {
                    "keywords": [
                        "中金公司",
                        "医药",
                        "新能源",
                        "沪深300"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}